Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cells to enhance rotator cuff repair
2010-024664-17Phase 2Terminated
- Sponsor
- Bioinova
- Start
- Sep 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human autologous mesenchymal stem cells in rotator cuff tear, sponsored by Bioinova. Primary endpoint: Safety and tolerability. Started Sep 2012; status: terminated.
02
Drugs
human autologous mesenchymal stem cells
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on 2010-024664-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024664-17.